[The clinico-immunological evaluation of the efficacy of indirect endolymphatic therapy with bicillin-3 in erysipelas patients].
Ambalov
Iu M
IuM
Poliak
A I
AI
Levina
L D
LD
Aĭtkuluev
N S
NS
Kovalenko
A P
AP
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D004359:Drug Therapy, Combination / Q000008:administration & dosage*; D004886:Erysipelas / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007272:Injections, Intralymphatic; D007866:Leg; D008875:Middle Aged; D010400:Penicillin G / Q000008:administration & dosage; D010401:Penicillin G Benzathine / Q000008:administration & dosage; D010402:Penicillin G Procaine / Q000008:administration & dosage; D012008:Recurrence; D013997:Time Factors
C024657:benzathine benzylpenicillin, procaine benzylpenicillin, drug combination; D010402:Penicillin G Procaine; D010400:Penicillin G; D010401:Penicillin G Benzathine
Kliniko-immunologicheskaia otsenka éffektivnosti nepriamoĭ éndolimfaticheskoĭ terapii bitsillinom-3 u bol'nykh rozheĭ.